Cargando…

Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia

BACKGROUND: Community pharmacists have regular interactions with people living with type 2 diabetes to supply medications, and have a potential role in supporting other primary care professionals in the screening, management, monitoring and facilitation of timely referral of microvascular complicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodhams, Louise, Chalmers, Leanne, Hillis, Graham S., Sim, Tin Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939021/
https://www.ncbi.nlm.nih.gov/pubmed/36811008
http://dx.doi.org/10.7717/peerj.14849
_version_ 1784890752842596352
author Woodhams, Louise
Chalmers, Leanne
Hillis, Graham S.
Sim, Tin Fei
author_facet Woodhams, Louise
Chalmers, Leanne
Hillis, Graham S.
Sim, Tin Fei
author_sort Woodhams, Louise
collection PubMed
description BACKGROUND: Community pharmacists have regular interactions with people living with type 2 diabetes to supply medications, and have a potential role in supporting other primary care professionals in the screening, management, monitoring and facilitation of timely referral of microvascular complications. This study aimed to investigate the contemporary and future roles of community pharmacists in diabetes-related microvascular complication management. METHODS: This study involved an online Australian nation-wide survey of pharmacists administered via Qualtrics® and distributed through social media platforms, state and national pharmacy organisations, and via major banner groups. Descriptive analyses were undertaken using SPSS. RESULTS: Among 77 valid responses, 72% of pharmacists already provided blood pressure and blood glucose monitoring services for the management of type 2 diabetes. Only 14% reported providing specific microvascular complication services. Over 80% identified a need for a comprehensive microvascular complication monitoring and referral service, and agreed it is feasible and within the scope of practice of a pharmacist. Almost all respondents agreed that they would implement and provide a monitoring and referral service if provided with appropriate training and resources. Potential barriers to service implementation were competing demands and lack of remuneration and awareness among consumers and health professionals. CONCLUSIONS: Type 2 diabetes services in Australian community pharmacies do not currently focus on microvascular complication management. There appears to be strong support for implementing a novel screening, monitoring and referral service via community pharmacy to facilitate timely access to care. Successful implementation would require additional pharmacist training, and identification of efficient pathways for service integration and remuneration.
format Online
Article
Text
id pubmed-9939021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-99390212023-02-20 Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia Woodhams, Louise Chalmers, Leanne Hillis, Graham S. Sim, Tin Fei PeerJ Diabetes and Endocrinology BACKGROUND: Community pharmacists have regular interactions with people living with type 2 diabetes to supply medications, and have a potential role in supporting other primary care professionals in the screening, management, monitoring and facilitation of timely referral of microvascular complications. This study aimed to investigate the contemporary and future roles of community pharmacists in diabetes-related microvascular complication management. METHODS: This study involved an online Australian nation-wide survey of pharmacists administered via Qualtrics® and distributed through social media platforms, state and national pharmacy organisations, and via major banner groups. Descriptive analyses were undertaken using SPSS. RESULTS: Among 77 valid responses, 72% of pharmacists already provided blood pressure and blood glucose monitoring services for the management of type 2 diabetes. Only 14% reported providing specific microvascular complication services. Over 80% identified a need for a comprehensive microvascular complication monitoring and referral service, and agreed it is feasible and within the scope of practice of a pharmacist. Almost all respondents agreed that they would implement and provide a monitoring and referral service if provided with appropriate training and resources. Potential barriers to service implementation were competing demands and lack of remuneration and awareness among consumers and health professionals. CONCLUSIONS: Type 2 diabetes services in Australian community pharmacies do not currently focus on microvascular complication management. There appears to be strong support for implementing a novel screening, monitoring and referral service via community pharmacy to facilitate timely access to care. Successful implementation would require additional pharmacist training, and identification of efficient pathways for service integration and remuneration. PeerJ Inc. 2023-02-16 /pmc/articles/PMC9939021/ /pubmed/36811008 http://dx.doi.org/10.7717/peerj.14849 Text en © 2023 Woodhams et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Diabetes and Endocrinology
Woodhams, Louise
Chalmers, Leanne
Hillis, Graham S.
Sim, Tin Fei
Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia
title Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia
title_full Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia
title_fullStr Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia
title_full_unstemmed Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia
title_short Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia
title_sort developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in australia
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939021/
https://www.ncbi.nlm.nih.gov/pubmed/36811008
http://dx.doi.org/10.7717/peerj.14849
work_keys_str_mv AT woodhamslouise developingcommunitypharmacistsroleinthemanagementoftype2diabetesandrelatedmicrovascularcomplicationsanationwidesurveyinaustralia
AT chalmersleanne developingcommunitypharmacistsroleinthemanagementoftype2diabetesandrelatedmicrovascularcomplicationsanationwidesurveyinaustralia
AT hillisgrahams developingcommunitypharmacistsroleinthemanagementoftype2diabetesandrelatedmicrovascularcomplicationsanationwidesurveyinaustralia
AT simtinfei developingcommunitypharmacistsroleinthemanagementoftype2diabetesandrelatedmicrovascularcomplicationsanationwidesurveyinaustralia